Your browser doesn't support javascript.
loading
Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?
van Adrichem, Roxanne C S; Kamp, Kimberly; van Deurzen, Carolien H M; Biermann, Katharina; Feelders, Richard A; Franssen, Gaston J H; Kwekkeboom, Dik J; Hofland, Leo J; de Herder, Wouter W.
Neuroendocrinology ; 103(5): 560-6, 2016.
Article in En | MEDLINE | ID: mdl-26536001
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Stomach Neoplasms / Octreotide / Radionuclide Imaging / Treatment Outcome / Receptors, Somatostatin / Neuroendocrine Tumors / Intestinal Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neuroendocrinology Year: 2016 Document type: Article Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Stomach Neoplasms / Octreotide / Radionuclide Imaging / Treatment Outcome / Receptors, Somatostatin / Neuroendocrine Tumors / Intestinal Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Neuroendocrinology Year: 2016 Document type: Article Country of publication: Switzerland